Discovery of the Triazolo[1,5-a]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming …
Targeting P-glycoprotein (ABCB1 or P-gp) has been recognized as a promising strategy to
overcome multidrug resistance. Here, we reported our medicinal chemistry efforts that led to …
overcome multidrug resistance. Here, we reported our medicinal chemistry efforts that led to …
Discovery of the Triazolo[1,5-a]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming …
S Wang, SQ Wang, QX Teng, ZN Lei… - Journal of Medicinal …, 2021 - europepmc.org
Targeting P-glycoprotein (ABCB1 or P-gp) has been recognized as a promising strategy to
overcome multidrug resistance. Here, we reported our medicinal chemistry efforts that led to …
overcome multidrug resistance. Here, we reported our medicinal chemistry efforts that led to …
Discovery of the Triazolo [1, 5-a] Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming …
S Wang, SQ Wang, QX Teng, ZN Lei… - Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Targeting P-glycoprotein (ABCB1 or P-gp) has been recognized as a promising strategy to
overcome multidrug resistance. Here, we reported our medicinal chemistry efforts that led to …
overcome multidrug resistance. Here, we reported our medicinal chemistry efforts that led to …